1. Home
  2. PSTX

PSTX

Poseida Therapeutics Inc.

Logo Poseida Therapeutics Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.

Founded: 2014 Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 290.4M IPO Year: 2020
Target Price: $14.67 AVG Volume (30 days): 744.0K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.37 EPS Growth: N/A
52 Week Low/High: $1.54 - $4.27 Next Earning Date: 05-07-2024
Revenue: $64,703,000 Revenue Growth: -50.42%
Revenue Growth (this year): -26.43% Revenue Growth (next year): -39.29%

Share on Social Networks: